Exploring transitions to injecting among young adult non-medical opioid users

探索年轻成人非医疗阿片类药物使用者向注射的转变

基本信息

  • 批准号:
    8845186
  • 负责人:
  • 金额:
    $ 16.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-15 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Non-medical prescription opioid (NMPO) use is a serious public health problem in the United States. Although NMPO-related health and social harms, including opioid dependence, lost productivity, and overdose are major causes of morbidity and mortality, initiation of injection drug use and infectious disease specific consequences, including HIV and hepatitis C virus (HCV) infection, are crucially understudied. The objective of this project is to examine the context and epidemiology of injection drug use as well as HIV- and HCV-related risk behaviors among young adult NMPO users. The ultimate goal of this pilot study is to use these data to inform the development of a prospective cohort study to determine the multi-level risk factors for initiation of injection drug use in this population. Specifically, the proposed stdy has the following aims: (1) to compare and evaluate the feasibility of two novel sampling methods to recruit young adult NMPO users; and (2), to explore social, macro-social, and drug-related factors associated with HIV risk behavior and transitions to injection drug use among young adult NMPO users. To achieve these aims, we will conduct a pilot study of 200 NMPO users aged 18 to 25 who reside in Rhode Island (RI), a state that is among the highest in the prevalence of NMPO use among young adults. To achieve Aim 1, we will compare the efficiency, cost, and sample composition of two novel recruitment strategies, including a combination of targeted canvassing and respondent-driven sampling, as well as mixed internet-based recruitment from drug information and social media websites. To achieve Aim 2, we will assess non-injectors' perceptions of risk for initiating injection. We will also examine the relationship between social, macro-social, and drug-related risk factors (e.g., diversion from family members, social network characteristics, denial of opioids for pain control, progression to heroin use following abuse-deterrent reformulations) and HIV risk behaviors and transitions to injection drug use. Finally, to assess receipt of opioid prescriptions from multiple physicians as risk factor for injecting initiation, we will obtain past-year opioid dispensation histories by conducting a deterministic, confidential data linkage to the RI prescription monitoring program. This study has important implications for improved prescription opioid exposure assessments as well as the development of novel sampling methodologies to access members of a population that, due to the hidden and amorphous nature of NMPO use, has been challenging to study. This research will address several questions central to the urgent public health challenges facing non-medical users of prescription opioids in the US, particularly in the context of evolving technologies and abuse-deterrent formulations to prevent injecting and opioid abuse. Taken together, the results of this work will inform the development of interventions to prevent injectin initiation and reduce HIV transmission in NMPO-using populations, and avert unintended adverse consequences of ongoing prescription opioid prescribing and policy changes.
非医疗处方阿片类药物(NMPO)的使用是美国严重的公共卫生问题。虽然NMPO相关的健康和社会危害,包括阿片类药物依赖,丧失生产力和过量是发病率和死亡率的主要原因,但注射药物使用的开始和传染病的具体后果,包括艾滋病毒和丙型肝炎病毒(HCV)感染,是至关重要的研究不足。该项目的目的是研究注射吸毒的背景和流行病学以及年轻成年NMPO使用者中HIV和HCV相关的风险行为。本初步研究的最终目标是使用这些数据为前瞻性队列研究的开发提供信息,以确定该人群中开始注射药物使用的多水平风险因素。具体而言,拟议的研究有以下目的:(1)比较和评估两种新的抽样方法招募年轻成人NMPO用户的可行性;(2),探讨社会,宏观社会和药物相关因素与艾滋病毒的危险行为和过渡到注射毒品使用的年轻成人NMPO用户。为了实现这些目标,我们将对居住在罗得岛(RI)的200名18至25岁的NMPO使用者进行试点研究,罗德岛是年轻人使用NMPO流行率最高的州之一。为了实现目标1,我们将比较两种新的招募策略的效率,成本和样本组成,包括有针对性的拉票和响应者驱动的抽样相结合,以及混合基于互联网的药物信息和社交媒体网站的招聘。为了实现目标2,我们将评估非注射者对开始注射的风险的看法。我们还将研究社会、宏观社会和药物相关风险因素之间的关系(例如,从家庭成员转移、社会网络特征、拒绝使用阿片类药物控制疼痛、在滥用威慑重新配制后发展为使用海洛因)以及艾滋病毒风险行为和过渡到注射吸毒。最后,为了评估从多名医生处接受阿片类药物处方作为开始注射的风险因素,我们将通过与RI处方监测计划进行确定性的机密数据链接,获得过去一年的阿片类药物处方史。这项研究对改善处方阿片类药物暴露评估以及开发新的采样方法以访问人群成员具有重要意义,由于NMPO使用的隐藏性和无定形性,研究一直具有挑战性。这项研究将解决美国处方阿片类药物非医疗使用者面临的紧迫公共卫生挑战的几个核心问题,特别是在不断发展的背景下, 预防注射和类阿片滥用的技术和防滥用制剂。总而言之,这项工作的结果将为制定干预措施提供信息,以防止注射开始并减少NMPO使用人群中的艾滋病毒传播,并避免持续的阿片类处方药处方和政策变化带来意想不到的不良后果。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Social context and perspectives of non-medical prescription opioid use among young adults in Rhode Island: A qualitative study.
罗德岛州年轻人非医疗处方阿片类药物使用的社会背景和观点:一项定性研究。
  • DOI:
    10.1111/ajad.12466
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yedinak,JesseL;Kinnard,ElizabethN;Hadland,ScottE;Green,TraciC;Clark,MelissaA;Marshall,BrandonDL
  • 通讯作者:
    Marshall,BrandonDL
Access to substance use treatment among young adults who use prescription opioids non-medically.
Injection drug use and overdose among young adults who use prescription opioids non-medically.
  • DOI:
    10.1016/j.addbeh.2017.07.017
  • 发表时间:
    2018-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Liebling EJ;Green TC;Hadland SE;Marshall BDL
  • 通讯作者:
    Marshall BDL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brandon David Lewis Marshall其他文献

Brandon David Lewis Marshall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brandon David Lewis Marshall', 18)}}的其他基金

DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    10349581
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    9762301
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
DAT-18-06 使用优化的纳洛酮分配策略预防和救援芬太尼和其他阿片类药物过量(PROFOUND)
  • 批准号:
    10588267
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10162577
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10411973
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms
罗德岛州青少年处方和非法药物研究 (RAPIDS):应对芬太尼及相关危害
  • 批准号:
    10629228
  • 财政年份:
    2019
  • 资助金额:
    $ 16.62万
  • 项目类别:
Core B: Data and Research Methods
核心 B:数据和研究方法
  • 批准号:
    10711727
  • 财政年份:
    2018
  • 资助金额:
    $ 16.62万
  • 项目类别:
Core B: Data and Research Methods
核心 B:数据和研究方法
  • 批准号:
    10256005
  • 财政年份:
    2018
  • 资助金额:
    $ 16.62万
  • 项目类别:
Core B: Data and Research Methods
核心 B:数据和研究方法
  • 批准号:
    10006598
  • 财政年份:
    2018
  • 资助金额:
    $ 16.62万
  • 项目类别:
Exploring transitions to injecting among young adult non-medical opioid users
探索年轻成人非医疗阿片类药物使用者向注射的转变
  • 批准号:
    8731017
  • 财政年份:
    2014
  • 资助金额:
    $ 16.62万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.62万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 16.62万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 16.62万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了